2023
DOI: 10.3350/cmh.2023.0061
|View full text |Cite
|
Sign up to set email alerts
|

Lean vs. obese phenotypes of nonalcoholic fatty liver disease: similar or different?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 18 publications
0
2
0
Order By: Relevance
“…Furthermore, the severity of NAFLD has been shown to be driven, in part, by single-nucleotide polymorphisms in genes involved in lipid metabolism, oxidative stress, insulin signaling, and fibrogenesis ( 36 ). The clinical outcomes of non-obese or lean individuals with NAFLD compared with obese individuals with NAFLD remain unclear due to variation across recent studies ( 37 , 38 ). However, the presence of hepatic steatosis in individuals without a known cause of chronic liver disease, including excessive alcohol consumption, is the hallmark of NAFLD ( 39 ).…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, the severity of NAFLD has been shown to be driven, in part, by single-nucleotide polymorphisms in genes involved in lipid metabolism, oxidative stress, insulin signaling, and fibrogenesis ( 36 ). The clinical outcomes of non-obese or lean individuals with NAFLD compared with obese individuals with NAFLD remain unclear due to variation across recent studies ( 37 , 38 ). However, the presence of hepatic steatosis in individuals without a known cause of chronic liver disease, including excessive alcohol consumption, is the hallmark of NAFLD ( 39 ).…”
Section: Discussionmentioning
confidence: 99%
“…13 Although some data suggest that lean NAFLD individuals have less-severe disease and may have a more favorable outcome than their obese counterparts, 14 lean NAFLD individuals also experienced both hepatic and extrahepatic complications. [15][16][17] The histological severity in non-obese NAFLD compared to obese counterparts seemed similar in terms of lobular inflammation and ballooning. 14,15,18 In longitudinal biopsy-proven NAFLD studies, the mortality risk of lean or nonobese NAFLD patients is similar to that of obese NAFLD patients.…”
Section: See Article On Page 987mentioning
confidence: 94%